Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre StudyTiago Torres, Paolo Gisondi, Ricardo Romiti et al.|American Journal of Clinical Dermatology|2024Cited by 58
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Howard Sofen, Craig L. Leonardi et al.|Journal of Dermatological Treatment|2016Cited by 56
41176 Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)Hannah Peterson, April W. Armstrong, Edwin Korouri et al.|Journal of the American Academy of Dermatology|2023Cited by 3
Global Comparison of COVID-19 Vaccination Rates among Psoriasis PatientsEdwin Korouri, April W. Armstrong, Charlotte Jeong et al.|Life|2024Cited by 2
Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)Hannah Peterson, April W. Armstrong, Edwin Korouri et al.|Unknown|2023Cited by 0